ORGO — Organogenesis Holdings Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1661181 ·
Last close
$0.81
Market Cap
$105.35M
52W High
$5.99
52W Low
$0.73
ADV30
1,039,985
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 45,457,000 23,559,000 -29,489,000 -29,629,000 368,905,000 21,326,000 106,164,000
Jun 2026 42,805,000 19,132,000 -52,180,000 -96,267,000 406,446,000 46,097,000 118,314,000
Mar 2026 36,250,000 10,478,000 -68,891,000 -53,156,000 519,992,000 91,379,000 138,645,000
Dec 2025 225,071,000 175,153,000 65,229,000 43,700,000 598,730,000 93,679,000 164,812,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$31,973,000
Investing CF
$-11,133,000
Financing CF
$-47,731,000
CapEx
$-11,133,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.86
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-152,501,000
Inventory
$29,280,000
Receivables
$100,937,000
ST Investments
—
EBIT TTM
$-34,193,000
Pretax Income TTM
$-34,766,000
Interest Exp TTM
—
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$352,047,008
EBITDA
$-56,943,000
Free Cash Flow
$24,084,250
Enterprise Value
$291,748,768
Total Cash
$21,326,000
Total Debt
$64,516,000
Shares Out
129,801,720
Trailing EPS
$-1.20
Book Value
$0.92
ROE
-41.7%
ROA
-11.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 563,030,000 55,869,000 37,032,000 598,730,000 164,812,000 433,918,000 -10,309,000
Dec 2024 482,043,000 21,518,000 861,000 497,886,000 112,570,000 385,316,000 14,208,000
Dec 2023 433,140,000 12,525,000 4,945,000 460,025,000 181,362,000 278,663,000 30,917,000
Dec 2022 450,893,000 22,304,000 15,532,000 449,359,000 183,690,000 265,669,000 24,859,000

TTM Snapshot

Revenues TTM
$457,454,000
NetIncome TTM
$-84,156,000
OpCashFlow TTM
—
Assets (Latest)
$406,446,000
Forward EPS
$-0.31

Peers — same industry

TickerNameMarket CapLastDaily %
NRXP NRX Pharmaceuticals, Inc. $106.07M $2.45 —
OKUR OnKure Therapeutics, Inc. $104.50M $2.58 —
CATX Perspective Therapeutics, Inc. $103.84M $0.86 —
NERV Minerva Neurosciences, Inc. $103.13M $2.16 —
OGI ORGANIGRAM GLOBAL INC. $101.90M $0.71 —

News headlines (Yahoo Finance, 1h cache)

Organogenesis Holdings Inc (ORGO) Q3 2026 Earnings Call Highlights: Market Bottom, Cost Cuts, ...
2026-11-07 15:09 · Yahoo
Organogenesis Holdings Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
Organogenesis: 3 Key Takeaways for Long-Term Investors
2026-11-06 11:45 · Yahoo
Organogenesis (ORGO) Q3 2026 Earnings Call Transcript
2026-11-06 09:30 · Yahoo
Organogenesis: Q3 Earnings Snapshot
2026-11-05 22:05 · Yahoo
Organogenesis Holdings Inc. Reports Third Quarter 2026 Financial Results
2026-11-05 21:05 · Yahoo
Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers
2026-10-12 20:10 · Yahoo
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026
2026-10-12 20:05 · Yahoo
Organogenesis (ORGO) Q2 2026 Earnings Call Transcript
2026-08-13 23:46 · Yahoo
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
2026-07-09 11:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.